Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Oct 17:14:92.
doi: 10.1186/1471-2253-14-92. eCollection 2014.

Three suspected cases of sugammadex-induced anaphylactic shock

Tomonori Takazawa  1 , Yukinari Tomita  2 , Nagahide Yoshida  3 , Akihiro Tomioka  4 , Tatsuo Horiuchi  1 , Chie Nagata  1 , Masaki Orihara  1 , Makiko Hardy Yamada  1 , Shigeru Saito  1
Affiliations
Case Reports

Three suspected cases of sugammadex-induced anaphylactic shock

Tomonori Takazawa et al. BMC Anesthesiol. .

Abstract

Background: Sugammadex has a unique mechanism of action and is widely used because of its safety and efficacy. A few recent reports have described allergic reactions to clinical doses of sugammadex. We hereby describe another series of cases of possible anaphylaxis to sugammadex.

Case presentation: We present three suspected cases of sugammadex-induced anaphylactic shock, including a 13-year-old boy who underwent laparoscopic appendectomy, a 75-year-old woman who underwent left knee arthroplasty, and a 34-year-old man who underwent left pansinectomy for sinobronchitis. All three patients received general anesthesia with rocuronium and their tracheas were intubated. Shortly after injection of sugammadex for reversal of rocuronium, all of them experienced a decrease in blood pressure along with mucocutaneous erythema. In the most severe case, reintubation after extubation was required due to difficulty in manual ventilation. All patients recovered with anti-allergic therapy. On later investigation, all three patients had a positive skin reaction to sugammadex.

Conclusion: Our results suggest that physicians using sugammadex should be aware of the possibility of sugammadex-induced anaphylaxis.

Keywords: Anaphylactic shock; General anesthesia; Sugammadex.

PubMed Disclaimer

References

    1. Paton F, Paulden M, Chambers D, Heirs M, Duffy S, Hunter JM, Sculpher M, Woolacott N. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation. Br J Anaesth. 2010;105(5):558–567. doi: 10.1093/bja/aeq269. - DOI - PMC - PubMed
    1. Cammu G, De Kam PJ, Demeyer I, Decoopman M, Peeters PA, Smeets JM, Foubert L. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers. Br J Anaesth. 2008;100(3):373–379. doi: 10.1093/bja/aem402. - DOI - PubMed
    1. Godai K, Hasegawa-Moriyama M, Kuniyoshi T, Kakoi T, Ikoma K, Isowaki S, Matsunaga A, Kanmura Y. Three cases of suspected sugammadex-induced hypersensitivity reactions. Br J Anaesth. 2012;109(2):216–218. doi: 10.1093/bja/aes137. - DOI - PubMed
    1. Menendez-Ozcoidi L, Ortiz-Gomez JR, Olaguibel-Ribero JM, Salvador-Bravo MJ. Allergy to low dose sugammadex. Anaesthesia. 2011;66(3):217–219. doi: 10.1111/j.1365-2044.2010.06611.x. - DOI - PubMed
    1. Motoyama Y, Izuta S, Maekawa N, Chuma R. [Case of anaphylactic reaction caused by sugammadex] Masui. 2012;61(7):746–748. - PubMed
Pre-publication history
    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2253/14/92/prepub

Publication types